Image Source: PixabayAnother wipeout: this one, the lovely pharma opportunists at Moderna (MRNA), which has already lost 80% of its value. Just 20% to go!More By This Author:Sky High July Review Monro: A Promising Short Opportunity Despite Low VolumeElectronic Arts: A Strong Long-Term Investment at Lifetime High